{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1116.208",
  "meta": {
    "versionId": "4",
    "lastUpdated": "2018-04-20T12:05:19.000-04:00"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.208",
  "version": "Draft",
  "name": "Lapatinib",
  "status": "draft",
  "date": "2018-04-20T12:05:19-04:00",
  "publisher": "American Society of Clinical Oncology Steward",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05022022",
        "concept": [
          {
            "code": "672147",
            "display": "lapatinib 250 MG"
          },
          {
            "code": "672149",
            "display": "lapatinib 250 MG Oral Tablet"
          },
          {
            "code": "672150",
            "display": "lapatinib 250 MG [Tykerb]"
          },
          {
            "code": "672151",
            "display": "lapatinib Oral Tablet [Tykerb]"
          },
          {
            "code": "672152",
            "display": "lapatinib 250 MG Oral Tablet [Tykerb]"
          }
        ]
      }
    ]
  }
}